In US OTC Monograph Program, ‘FDR’ Spells Appealing FDA's Rejections Of Change Requests

‘FDR’ Spells Process To Appeal FDA Rejections Of Requests For OTC Monograph Changes

Draft guidance adds “formal dispute resolution” to other terms becoming common in OTC drug sector since agency began overhaul of monograph drug program authorized in 2020. Others are OMOR, for OTC monograph order request, and OMUFA, for user fee program also authorized.

• Source: Shutterstock

An acronym associated with disagreement with US Food and Drug Administration decisions and already known to firms marketing drugs available through applications also could become common for manufacturers of OTC monograph drugs, FDR.

A draft guidance the FDA Center for Drug Evaluation and Research published on 22 June adds “formal dispute resolution”...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from International

More from Geography

Haleon Survey Finds Brits Not Paying Enough Attention To Gum Health

 
• By 

Gum health awareness among British consumers could be better, a recent Haleon survey finds.

UK FSA Issues New Guidelines For CBD And THC Max Levels

 
• By 

Based on advice from its advisory committees, the UK's Food Standards Agency is encouraging businesses to meet an acceptable daily intake of 10mg CBD per day and a safe upper limit of 0.07mg THC per day.

Scope Launches Eyelid-Friendly Eye Cream In The UK

 
• By 

Eyelids have the "thinnest, most sensitive skin on the body" and are "highly prone to dehydration," which is why Scope has launched new Optase Life Sensitive Eye Daily Renewal Cream.